These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 28724315)

  • 21. Five-year follow-up outcome after catheter ablation of persistent atrial fibrillation using a sequential biatrial linear defragmentation approach: What does atrial fibrillation termination during the procedure imply?
    Miyazaki S; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Hirao K; Iesaka Y
    Heart Rhythm; 2017 Jan; 14(1):34-40. PubMed ID: 27590435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interventional therapy of atrial fibrillation: possibilities and limitations].
    Willems S; Drewitz I; Steven D; Hoffmann BA; Meinertz T; Rostock T
    Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S48-54. PubMed ID: 20221979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?: a randomized comparison of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation.
    Caponi D; Corleto A; Scaglione M; Blandino A; Biasco L; Cristoforetti Y; Cerrato N; Toso E; Morello M; Gaita F
    Europace; 2010 Aug; 12(8):1098-104. PubMed ID: 20400766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring.
    Primo J; Gonçalves H; Macedo A; Russo P; Monteiro T; Guimarães J; Costa O
    Rev Port Cardiol; 2017; 36(7-8):535-546. PubMed ID: 28709762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal pattern/episode duration-based classification of atrial fibrillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management?
    Hammond-Haley M; Providência R; Lambiase PD
    Europace; 2018 Nov; 20(FI_3):f288-f298. PubMed ID: 29016766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
    Masuda M; Fujita M; Iida O; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Okuno S; Ohashi T; Tsuji A; Mano T
    Int J Cardiol; 2018 Apr; 257():97-101. PubMed ID: 29506746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Persistent Atrial Fibrillation: A Distinct Arrhythmia Subentity of an Ablation Population.
    Konrad T; Theis C; Mollnau H; Sonnenschein S; Ocete BQ; Bock K; Münzel T; Rostock T
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1289-94. PubMed ID: 26303513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.
    Du X; Guo L; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Liu X; Yin H; Xuan J; Dong J; Ma C
    BMC Cardiovasc Disord; 2017 Jul; 17(1):204. PubMed ID: 28750608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablation.
    Okawa K; Miyoshi T; Tsukuda S; Hara S; Matsuo N; Nishibe N; Sogo M; Okada T; Nosaka K; Sakane K; Doi M; Morita H; Ito H
    Int J Cardiol; 2017 Oct; 244():180-185. PubMed ID: 28668398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review.
    Deng H; Bai Y; Shantsila A; Fauchier L; Potpara TS; Lip GYH
    Clin Res Cardiol; 2017 Oct; 106(10):813-823. PubMed ID: 28560516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
    Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
    Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation.
    Hsieh MH; Tai CT; Lee SH; Tsao HM; Lin YK; Huang JL; Chan P; Chen YJ; Kuo JY; Tuan TC; Hsu TL; Kong CW; Chang SL; Chen SA
    J Cardiovasc Electrophysiol; 2005 May; 16(5):457-61. PubMed ID: 15877612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis.
    Wang M; Cai S; Sun L; Zhao Q; Feng W
    Cardiol J; 2016; 23(4):416-21. PubMed ID: 27296156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Termination of long-lasting persistent versus short-lasting persistent and paroxysmal atrial fibrillation by ablation.
    Fiala M; Chovancík J; Nevralová R; Neuwirth R; Jiravský O; Januska J; Branny M
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):985-97. PubMed ID: 18684255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study.
    Middeldorp ME; Pathak RK; Meredith M; Mehta AB; Elliott AD; Mahajan R; Twomey D; Gallagher C; Hendriks JML; Linz D; McEvoy RD; Abhayaratna WP; Kalman JM; Lau DH; Sanders P
    Europace; 2018 Dec; 20(12):1929-1935. PubMed ID: 29912366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
    Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
    Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study of atrial fibrillation termination during ablation guided by automated detection of fractionated electrograms.
    Porter M; Spear W; Akar JG; Helms R; Brysiewicz N; Santucci P; Wilber DJ
    J Cardiovasc Electrophysiol; 2008 Jun; 19(6):613-20. PubMed ID: 18462320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.
    Takigawa M; Takahashi A; Kuwahara T; Okubo K; Takahashi Y; Watari Y; Takagi K; Fujino T; Kimura S; Hikita H; Tomita M; Hirao K; Isobe M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):267-73. PubMed ID: 24610740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.